Evidence map›Paper›PMID 33693121›Full record

ArticleCirculation reports2019

Effect of Alirocumab and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaque in Coronary Artery Disease Seen on Near-Infrared Spectroscopy Intravascular Ultrasound (ANTARES).

Hiromasa Otake, Kosuke Tanimura, Yoichiro Sugizaki, Takayoshi Toba, Hiroyuki Kawamori, Toshiro Shinke, Ken-Ichi Hirata

Registry-linked trialOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06606821 (The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606821 phase4recruitingstarted 2024, after this paper: background citation

The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study

Ran2024Enrolled124Registered outcomes23Posted comparisons0ConditionsAtherosclerosis Cardiovascular Disease, Chronic Coronary Artery Disease, Coronary Artery Disease, Coronary Microvascular DysfunctionArmsPlacebo, Tirzepatide
PMID 30293770PMID 27295427PMID 30473097PMID 27633186PMID 35658024PMID 34170647PMID 25537494PMID 32052833PMID 32437302PMID 32746822PMID 33309175PMID 34724592other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hiromasa OtakeDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Kosuke TanimuraDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Yoichiro SugizakiDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Takayoshi TobaDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Hiroyuki KawamoriDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Toshiro ShinkeDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Ken-Ichi HirataDepartment of Cardiology, Kobe University Graduate School of Medicine Kobe Japan.
Kobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlirocumabAtherosclerotic plaqueLipid core plaqueNear-infrared intravascular ultrasoundThin-cap fibroatheroma

Identifiers

PMID33693121
PMCPMC7890294
OpenAlexW2913308377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.